B

Babithajain

Active Director Designated Partner DIN 07869487
DIN 07869487 First appointment Sep 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 1 historical roles
Total affiliations 2 Since Sep 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Babithajain

Data last updated:

Babithajain is a Designated Partner at Remedi Speciality Medicines Llp (since 2021). The companies operate in Pharma. Earlier, Babithajain was a Director at Tricept Pharmaceuticals Private Limited (2017–2022).

DIN 07869487
Primary Designation Designated Partner
Industry Pharma
First Appointment 13 Sep 2017
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Apr 20212016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Sep 20172017₹16.4 Lakh (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Babithajain

NameDINCompanyDesignation
Anil Kumar Jain Shanta07132216Remedi Speciality Medicines LlpDesignated Partner
Ashishkumar09149489Remedi Speciality Medicines LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Remedi Speciality Medicines Llp
Tricept Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Babithajain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babithajain

Babithajain currently holds 1 directorship: Remedi Speciality Medicines Llp (Designated Partner, since 01 Apr 2021).

Babithajain was first appointed on 13 Sep 2017 as Director at Tricept Pharmaceuticals Private Limited. The most recent appointment on record is 01 Apr 2021 at Remedi Speciality Medicines Llp.

Babithajain held 1 earlier board appointment: Tricept Pharmaceuticals Private Limited (Director, 13 Sep 2017 to 15 Mar 2022).

The current boards of Babithajain's companies include Anil Kumar Jain Shanta (Remedi Speciality Medicines Llp), Ashishkumar (Remedi Speciality Medicines Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available